Victor V. Gogolak

Founder and Chief Executive Officer, brings over 30 years of scientific, technology and industry experience to DrugLogic. He was a vice-president in the commercial sector of Booz, Allen & Hamilton (BAH), where he led the company's thrust into drug safety and surveillance. He was responsible for marketing and managing over $13 million annually in project sales; his implementation projects included developing a world-class web-based adverse event reporting system for pharmaceutical companies. Prior to joining BAH, he was one of the six founding shareholders of the Titan Corp., where he developed a line of business supporting government and defense use of technology. He holds a B.S. in physics, a B.S. in philosophy and an M.S. in mathematics from Fordham University.

Stephen P. Meyer

Chief Financial Officer, has over 28 years of general, information technology, and financial management experience. He has been Chief Information Officer (CIO), Chief Financial Officer (CFO) and Group President of companies including Science Applications International Corporation (SAIC) $6 billion in revenue, The Titan Corporation (NYSE-TTN) $1 billion in revenue, and REMEC (Nasdaq-REMC). As chief information officer he directed the successful implementation of a worldwide distributed information management system, as chief financial officer he engineered over $500 million in private and public, debt and equity transactions and as general manager grew an information technology business to over $40 million in annual revenue.

Steven A. Wordham

Chief Technology Officer and Vice President of Operations, has spent more than 15 years in the highly charged Information Technology industry, focusing primarily on corporate technical and operations objectives.  Steve has extensive experience with full lifecycle product development, seamlessly merging multiple environments through several acquisitions.  Steve has spent the past 10 years addressing and meeting the demands of the rapidly evolving risk management requirements in the healthcare and pharmaceutical industry.  He works closely with clients, responding to continuously developing product safety objectives, to ensure the optimal utilization of the clients risk management solutions.  In addition, Steve has been instrumental in strengthening several small businesses and startups making funding and successful acquisitions possible.

Long Doan

Chief Architect, has over 15 years of experience in the design and implementation of multi-user, real-time communication networks, large-scale data mining, and internet-based content delivery systems. He was in charge of developing the communication platforms for Multicity.com, Inc. and Imvector, LLC; the CrimeStat project for the National Institute of Justice; and the content generation and delivery system for MindQ Publishing, Inc. He was also involved in developing the foundation of multiple real-time communication protocols at NxNetwork, Inc.

Paul R. Zapert

Vice President of Sales, has more than 20 years in the technology and software sales industry. Paul has held several management and technology sales positions with Dunn and Bradstreet Software, Sybase and recently, he was responsible for presales of a leading B2B e-commerce solutions provider as national presales manager at Saqqara Systems. He holds a B.S. in from Northeastern University.

Tanya G. Cote

Vice President of Administration, brings four years experience in healthcare-related fields and six years experience in education, public relations and database management. She has worked in educational environments managing student databases and coordinating Financial Aid activities and was responsible for organizing and designing recruitment events and admissions material.  Before that, Tanya spent time in clinical care settings, using her science background and training to work directly with patients in both the medical and dental fields. Tanya received a BA degree from Williams College with extensive course work in Chemistry and Biological Sciences. She has taken additional course work in Molecular Physiology at Harvard and in Microbiology at the University of Maryland.

Robin Samet

Director of Client Services, has more than 18 years management experience in the healthcare and life sciences industries, focusing primarily on strategic marketing, research, product planning and development.  She has significant expertise with the application of information technology in a broad array of pharmaceutical, hospital, and health insurance operations.  Robin brings more than seven years experience working with pharmaceutical companies to address risk management and drug safety needs during clinical research and in post-marketing settings.  Prior to joining DrugLogic, she held management positions at Galt Associates (now, Cerner Galt), eResearchTechnology and at several large health insurance companies where she focused on commercial, Medicare and Medicaid businesses.  Robin has a B.A. in Biology from Kalamazoo College, a B.S. in Nursing from Georgetown University and an M.B.A. from Marymount University.